Duvyzat Side Effects

Generic name: givinostat

Medically reviewed by Drugs.com. Last updated on Dec 10, 2024.

Note: This document provides detailed information about Duvyzat.

Applies to givinostat: oral suspension Side Effects associated with givinostat. Some dosage forms listed on this page may not apply specifically to the brand name Duvyzat.

Applies to givinostat: oral suspension.

Side effects include:

Most common adverse reactions (≥10%): diarrhea, abdominal pain, thrombocytopenia, nausea/vomiting, hypertriglyceridemia, pyrexia.

For healthcare professionals

Applies to givinostat: oral suspension.

General adverse events

The most common side effects were abdominal pain, diarrhea, hypertriglyceridemia, nausea or vomiting, pyrexia, and thrombocytopenia.^[Ref]

Cardiovascular

• Frequency not reported: QTc prolongation

Dermatologic

• Common (1% to 10%): Rash

Endocrine

• Common (1% to 10%): Hypothyroidism, increased thyroid stimulating hormone

Gastrointestinal

• Very common (10% or more): Abdominal pain (34%), diarrhea (37%), nausea/vomiting (32%)
• Common (1% to 10%): Constipation

Hematologic

• Very common (10% or more): Thrombocytopenia (33%)

Thrombocytopenia included a decreased platelet count and thrombocytopenia.

Metabolic

• Very common (10% or more): Hypertriglyceridemia (23%)
• Common (1% to 10%): Decreased appetite

Musculoskeletal

• Common (1% to 10%): Arthralgia, myalgia

Other

• Very common (10% or more): Pyrexia (13%)
• Common (1% to 10%): Fatigue

See also:

Frequently asked questions

• What are the new drugs for DMD (Duchenne muscular dystrophy)?

Further information

Duvyzat side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer